Invacare Corporation Receives Multiple Awards for Outstanding Product from Mobility Management Magazine
27 Juli 2022 - 5:00PM
Business Wire
Invacare Corporation (“Invacare”) (NYSE: IVC), a leading
manufacturer and distributor of medical equipment used in non-acute
care settings, has been recognized by Mobility Management magazine
in multiple product categories for outstanding product and
technology development in complex rehab.
“We are pleased to once again be recognized for our
industry-leading mobility products which deliver important user
benefits. These awards are a testament to our culture of innovation
and reflect our commitment to keeping our customers and end users
needs at the forefront of our design process,” said Matt Monaghan,
chairman, president and chief executive officer.
Invacare’s leading mobility and seating products span a breadth
of categories, with awards in the following categories:
Wheelchairs, Power: Group 3, multiple power:
- Invacare® AVIVA® Storm® RX Rear-Wheel Drive Power Wheelchair
with Ultra Low Maxx
Wheelchairs, Power: Group 3, single power:
- Invacare® AVIVA® Storm® RX Rear-Wheel Drive Power Wheelchair
with Ultra Low Maxx
Power Assist Systems:
- Alber™ e-motion™M25 Power Assist for Wheelchairs
Accessories, Wheelchair:
- Motion Concepts Maxx Resolve Swing-Away Joystick Mount
Positioning, Head:
- Motion Concepts Matrx® Loxx headrest hardware
Seat Cushions, skin protection &
positioning/E2607-2608
- Motion Concepts Matrx® PSP HD (Posture Seat Polymer)
Cushion
A complete list of winners can be found in the Aug/Sep 2022
issue of Mobility Management magazine and featured on the brand’s
website https://mobilitymgmt.com/productawards
About Invacare Corporation
Invacare Corporation (NYSE:IVC)(“Invacare” or the “company”) is
a leading manufacturer and distributor in its markets for medical
equipment used in non-acute care settings. At its core, the company
designs, manufactures and distributes medical devices that help
people to move, breathe, rest, and perform essential hygiene. The
company provides clinically complex medical device solutions for
congenital (e.g., cerebral palsy, muscular dystrophy, spina
bifida), acquired (e.g., stroke, spinal cord injury, traumatic
brain injury, post-acute recovery, pressure ulcers) and
degenerative (e.g., ALS, multiple sclerosis, chronic obstructive
pulmonary disease (COPD), elderly, bariatric) ailments. The
company's products are important parts of care for people with a
wide range of challenges, from those who are active and involved in
work or school each day and may need additional mobility or
respiratory support, to those who are cared for in residential care
settings, at home and in rehabilitation centers. The company sells
its products principally to home medical equipment providers with
retail and e-commerce channels, residential care operators,
distributors and government health services in North America,
Europe, and Asia/Pacific. For more information about the company
and its products, visit Invacare's website at www.invacare.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220727005333/en/
Marketing Contact Biola
Okunola Vice President, Marketing 440-329-6008
bokunola@invacare.com
Investor Contact Lois
Lee Director, Treasury, Investor Relations and Corporate
Communications 440-329-6435 LoisLee@invacare.com
Invacare (NYSE:IVC)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Invacare (NYSE:IVC)
Historical Stock Chart
Von Apr 2023 bis Apr 2024